Related Experiment Video

Updated: May 28, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

[Inhibition of SRC-1 expression in prostate cancer cells by RNAi and its significance]

Bo Peng1, Si-Qi Wang, Hong-Jun Zhao

  • 1Department of Urology, The First Affiliated Hospital of Wenzhou Medicine College, Wenzhou, Zhejiang 325000, China.

Zhonghua Nan Ke Xue = National Journal of Andrology
|October 4, 2011
PubMed
Abstract

Insights

Steroid receptor coactivator-1 (SRC-1) inhibition using RNA interference significantly reduced LNCap cell growth. Silencing SRC-1 may offer a therapeutic strategy for androgen-dependent prostate cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Expression Regulation

Context:

  • Steroid receptor coactivator-1 (SRC-1) is implicated in various cellular processes.
  • Prostate cancer progression, particularly to androgen-independence, may involve SRC-1.
  • LNCap cells are a human prostate cancer cell line model.

Purpose:

  • To investigate the inhibition of SRC-1 expression in LNCap cells via RNA interference (RNAi).
  • To evaluate the impact of silenced SRC-1 on LNCap cell proliferation.
  • To explore SRC-1 as a potential therapeutic target in prostate cancer.

Summary:

  • RNAi successfully reduced SRC-1 mRNA and protein expression in LNCap cells by up to 77% and significantly, respectively.
  • LNCap cell proliferation was inhibited in a time-dependent manner following SRC-1 silencing, reaching 60% inhibition by 96 hours.
  • Quantitative PCR and Western blot confirmed successful gene silencing, while CCK-8 assays measured cell growth inhibition.

Impact:

  • Demonstrates a direct correlation between SRC-1 expression levels and LNCap cell growth.
  • Suggests that high SRC-1 expression contributes to androgen-independent prostate cancer.
  • Highlights the potential of SRC-1 inhibition as a therapeutic approach for androgen-dependent prostate cancer.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...